Theoretically, yes some individuals may be able to inject GLP-1 medications less frequently (like every 10 or even 14 days), especially those with slower metabolism, strong response at low doses, or fewer metabolic demands
Another study assessed 524, 510, and 40 spontaneous reports of pancreatitis from the FDA Adverse Event Reporting System (FAERS) database, VigiBase, and CARD databases, respectively, to determine the potential association between SGLT2 inhibitors and pancreatitis
doi: 10.3389/fendo.2021.645617
Eli Lillys move to cut the price of Zepbound has received positive reactions from analysts who see it as a savvy move to expand market reach and address growing concerns over compounded medications
N Engl J Med 385(10):896907
Apply under tongue and hold for 60 seconds before swallowing for the best results